Aimei Health Technology Co., Ltd.
AFJK
Analytical Summary
Aimei Health Technology Co., Ltd. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
3-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|
| Return on Invested Capital (%) |
16.3%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
57.0%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
| Return on Capital (%) (%) |
-6.9%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-1.4%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— |
| Return on Common Equity (%) (%) |
-26.1%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-318%)
|
-172.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-1540%)
|
— |
Secondary lens
Benchmark Lens
Compare AFJK against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare AFJK against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for AFJK
No bullish signals detected
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How AFJK compares to all companies
Peer Comparison
AFJK vs similar peers
Compare AFJK with peers
Stack AFJK against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 4 days ago 3 years · 13 quarters